EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Origin of Kaposi's Sarcoma and Other KSHV‐Associated Sarcomas

Yan Yuan iD, Yao Ding

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Yan Yuan und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Herpesvirus 8, Human, Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 118 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi's sarcoma (KS) is a multicentric, polyclonal malignancy linked to Kaposi's sarcoma‐associated herpesvirus (KSHV) infection. While significant advances have been made in understanding KSHV virology and the clinical characteristics of KS, the precise mechanisms of pathogenesis and cellular origins remain elusive. This review integrates clinical observations with the latest cutting‐edge research to explore the nature and potential cellular precursors of KS. Multiple cell types have been proposed as potential KS oncogenic progenitors, including endothelial cells, mesenchymal stem cells (MSCs), and circulating endothelial progenitor cells (EPCs). KS progenitor cells are thought to be recruited to sites of inflammatory angio‐hyperplasia, where they may undergo KSHV‐mediated transformation. Intriguingly, KSHV has been shown to modulate both endothelial‐to‐mesenchymal transition (EndMT) and mesenchymal‐to‐endothelial transition (MEndT). By elucidating the mechanisms underlying KSHV‐mediated cellular plasticity and the synergistic effects of inflammatory angio‐hyperplasia and viral lytic reactivation in driving malignant transformation, we aim to deepen our understanding of KSHV‐driven oncogenesis. This review highlights promising avenues for future research, including the potential role of KSHV in other mesenchymal‐derived sarcomas, such as osteosarcoma. Ultimately, unraveling the complex interactions between KSHV, host cells, and the tumor microenvironment may pave the way for novel therapeutic strategies for patients with KS and related malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiHerpesvirus 8, HumanSarcomaHumansMesenchymal Stem CellsEndothelial CellsAnimals

Stichwörter der Autor:innen

Kaposi's sarcoma (KS)Kaposi's sarcoma‐associated herpesvirus (KSHV)endothelial‐to‐mesenchymal transition (EndMT)human herpesvirus Type 8 (HHV‐8)mesenchymal stem cellsmesenchymal‐to‐endothelial transition (MEndT)osteosarcoma

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Shandong University, Jinan, China.
  • Guangdong Cardiovascular Institute, and Medical Research Institute, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Yan Yuan

Zitieren

APA

Yuan, Y., & Ding, Y. (2025). The Origin of Kaposi's Sarcoma and Other KSHV‐Associated Sarcomas. Journal of Medical Virology. https://doi.org/10.1002/jmv.70675

Vancouver

Yuan Y, Ding Y. The Origin of Kaposi's Sarcoma and Other KSHV‐Associated Sarcomas. Journal of Medical Virology. 2025. doi:10.1002/jmv.70675

BibTeX
@article{Yuan2025,
  author = {Yuan, Yan and Ding, Yao},
  title = {The Origin of Kaposi's Sarcoma and Other KSHV‐Associated Sarcomas},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70675}
}
Kostenlos starten →